SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001358403-15-000006
Filing Date
2015-05-08
Accepted
2015-05-08 09:04:31
Documents
3
Period of Report
2015-05-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-kleaseagreementxmay2.htm 8-K 33322
2 EXHIBIT 99.1 exhibitpressreleaseleaseag.htm EX-99.1 7708
3 logo.jpg GRAPHIC 12685
  Complete submission text file 0001358403-15-000006.txt   59847
Mailing Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030
Business Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36783 | Film No.: 15844643
SIC: 2834 Pharmaceutical Preparations